• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWER PORT ISP M.R.I., 8FR GROSHONG; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWER PORT ISP M.R.I., 8FR GROSHONG; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 4808570J
Device Problems Fracture (1260); Material Twisted/Bent (2981)
Patient Problems Pain (1994); Swelling/ Edema (4577); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/26/2023
Event Type  malfunction  
Manufacturer Narrative
The catalog number has not been cleared in the us but is similar to the power port isp m.R.I., 8fr groshong that are cleared in the us.The pro code and 510 k number for the power port isp m.R.I., 8fr groshong are identified.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.However, an image was provided for review.The investigation of the reported event is currently underway.Expiry date: 11/2021.
 
Event Description
It was reported that one year eleven months and nine days post port placement procedure in right internal jugular vein, the circumferential cracks was allegedly found near tip of the removed catheter.It was further reported that the patient experienced pain and swelling around the port body.Reportedly, antiemetics was administered for experienced symptoms.The current status of the patient is stable.
 
Manufacturer Narrative
The astral device was returned to resmed for an investigation.Review of the device data logs confirmed the reported complaint, however, performance testing could not reproduce the reported complaint.Based on all available evidence and complaint investigations of a similar nature, the investigation determined the reported complaint was due to an intermittent connection with the battery.Resmed¿s risk analysis for this failure mode concludes that the risk is acceptable.Resmed reference#: (b)(4).
 
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the power port isp m.R.I., 8fr groshong that are cleared in the us.The pro code and 510 k number for the power port isp m.R.I., 8fr groshong are identified in d2 and g4.H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one powerport mri implantable port attached to a groshong catheter was returned for evaluation and one image was provided for review.Gross visual, microscopic visual, tactile and functional evaluations were performed on the returned device.The investigation is confirmed for the reported fracture issue as partial circumferential break and split were noted on the attached catheter and edges of both partial compound breaks on the attached catheter were noted to be uneven.Upon infusion, leaks were observed from the breaks on the attached catheter.The investigation is also confirmed for the identified material twist issue as the material was noted to be twisted in the provided image.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: (expiry date: 11/2021).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that one year eleven months and nine days post port placement procedure via right internal jugular vein, the circumferential cracks was allegedly found near tip of the removed catheter.It was further reported that when antiemetics were administered, pain and swelling were observed around the port body.The device was removed from the patient.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWER PORT ISP M.R.I., 8FR GROSHONG
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key16459594
MDR Text Key310420466
Report Number3006260740-2023-00582
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741175725
UDI-Public(01)00801741175725
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K063377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number4808570J
Device Lot NumberREEQ2923
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/16/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/02/2023
Initial Date FDA Received03/01/2023
Supplement Dates Manufacturer Received03/29/2023
05/08/2023
Supplement Dates FDA Received04/25/2023
05/12/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/25/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ANTIEMETICS
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexFemale
-
-